FOUNDATION PROPERTIES (CONSTRUCTION) LTD

Financial Health Score: D+ (Distressed/Guarded)

Explanation: While the patient is currently standing and active, it is suffering from severe financial bloating and acute liquidity stress. The balance sheet has expanded massively over the last year, but this growth is heavily reliant on short-term creditor financing, while the company's cash reserves have haemorrhaged. Furthermore, a massive £3.28 million investment was instantly written off as impaired, acting as a major bleed to shareholder funds. The business is surviving on life support provided by its creditors, and without immediate intervention to convert work-in-progress into cash, it is at high risk of a cardiac arrest (insolvency).

Key Vital Signs

1. Blood Pressure (Liquidity & Cash Flow): Dangerously Low * Cash Reserves: Plunged from £965,846 (2024) to just £121,641 (2025)—an 87% drop. The patient is bleeding cash rapidly. * Quick Ratio: With £2.66M tied up in stocks (Work in Progress) and £3.44M in debtors, the quick assets available to cover £5.63M of current liabilities are severely insufficient. The "blood pressure" is too low to sustain healthy operations without external transfusions.

2. Cholesterol Levels (Leverage & Debt): Dangerously High * Current Liabilities: Skyrocketed from £980,752 to £5,634,508 in a single year. * Other Creditors: The bulk of this debt (£5.49M) is classified as "Other creditors" rather than standard trade creditors. This suggests heavy reliance on inter-company loans, director loans, or short-term financing facilities. This is the equivalent of running entirely on adrenaline—it cannot be sustained long-term without blocking the arteries.

3. Digestive Health (Working Capital Cycle): Severely Constipated * Stocks (Work in Progress): Ballooned from £692,216 to £2,661,648. In the construction industry, this represents unbilled or incomplete projects. Money is trapped in the digestive tract, unable to be absorbed as cash. * Debtors: Surged from £84,432 to £3,441,284, with £3.18M classified as "Other debtors" (likely inter-company balances). The business is waiting on massive payouts, but until these clear, the system is backed up.

4. Organ Health (Asset Quality & Capital): Necrotic Tissue Detected * Investment Impairment: In 2025, the company injected £3,284,116 into "Shares in group undertakings" and immediately recognized an identical amount as an impairment loss. This is a surgical amputation of capital—a total write-off of a subsidiary investment that has severely scarred the balance sheet, dragging down the net assets despite the overall growth in size.

Diagnosis

Acute Onset Balance Sheet Blooding with Severe Cash Flow Dehydration

The financial data reveals a company experiencing extreme " growing pains," but the underlying vitals are highly unstable. The business has taken on a massive volume of work (evidenced by the surge in Work in Progress) and funded it through a massive intake of short-term "Other Creditors" rather than long-term financing or equity.

The most alarming symptom is the £3.28 million investment impairment. Injecting over £3 million into a group undertaking and immediately writing it off to zero suggests either a rescue operation for a failing subsidiary, a capital reorganization, or a catastrophic investment failure. This has severely weakened the company's financial immune system (shareholder funds), which actually fell from £821,785 to £675,693 despite the overall size of the business quadrupling.

While the Net Current Assets remain positive (£590,065), this is a fragile illusion of health. If the £2.66M in Work in Progress cannot be completed and invoiced promptly, or if the £3.18M in "Other Debtors" proves uncollectible, the company will instantly become insolvent, as the current liabilities far exceed the liquid assets available to pay them.

Recommendations

1. Fluid Resuscitation (Cash Flow Management): Immediately implement a 13-week rolling cash flow forecast. The £121k cash balance is dangerously low for a company of this size. You must accelerate the billing cycle to convert the £2.66M in Work in Progress into trade debtors, and subsequently into cash.
2. Arterial Clearance (Debt Restructuring): The £5.49M in "Other Creditors" represents a massive blockage. If these are inter-company or director loans, formalize them with long-term repayment schedules rather than leaving them as current liabilities. If they are short-term trade facilities, they must be refinanced or cleared to restore healthy leverage ratios.
3. Infection Control (Investment Review): The £3.28M impairment requires immediate forensic review. If the group undertaking is a dead limb, it must be severed cleanly to stop any further financial haemorrhaging. If it is an ongoing concern, strict ring-fencing must be applied to protect the parent company from further capital drains.
4. Cardiovascular Exercise (Working Capital Discipline): Do not take on new large-scale construction contracts until the current Work in Progress is converted to cash. The business needs to strengthen its heart before running another marathon.